Preview

Современная ревматология

Расширенный поиск

Неонатальная волчанка

https://doi.org/10.14412/1996-7012-2015-4-92-97

Полный текст:

Аннотация

Неонатальная волчанка (НВ) – симтомокомплекс, диагностируемый у новорожденных, матери которых часто страдают аутоиммунными ревматическими заболеваниями, и проявляющийся двумя основными признаками: поражением кожи и сердца. В статье приводятся данные из истории описания синдрома, современные представления о его патогенезе, рассмотрены клинические проявления заболевания, как типичные, так и более редкие; представлены подходы к терапии и профилактике НВ.

Об авторах

Н. М. Кошелева
ФГБНУ Научно-исследовательский институт ревматологии им. В.А. Насоновой
Россия
115522, Москва, Каширское шоссе, 34А


З. С. Алекберова
ФГБНУ Научно-исследовательский институт ревматологии им. В.А. Насоновой
Россия
115522, Москва, Каширское шоссе, 34А


Литература

1. Bresnihan B. Outcome and survival in systemic lupus erythematosus. Ann Rheum Dis. 1989 Jun;48(6):443-5. doi: 10.1136/ard.48.6.443.

2. McCuistion CH, Schoch ЕР. Jr. Possible discoid lupus erythematosus in newborn infant; report of a case with subsequent development of acute systemic lupus erythematosus in mother. AMA Arch Derm Syphilol. 1954 Dec;70(6):782-5. doi: 10.1001/archderm.1954.01540240088009.

3. Hull D, Binns BA, Joyce D. Congenital heart block and widespread fibrosis due to maternal lupus erythematosus. Arch Dis Child. 1966 Dec;41(220):688-90. doi: 10.1136/adc.41.220.688.

4. Wallgren G, Agorio E. Congenital complete A-V block in three siblings. Acta Paediatr. 1960 Jan;49:49-56. doi: 10.1111/j.1651-2227.1960.tb07703.x.

5. Scott JS, Maddison PJ, Taylor PV, et al. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med. 1983 Jul 28;309(4):209-12. doi: 10.1056/NEJM198307283090403.

6. Taylor PV, Scott JS, Gerlis LM, et al. Maternal antibodies against fetal cardiac antigens in congenital complete heart block. N Engl J Med. 1986 Sep 11;315(11):667-72. doi: 10.1056/NEJM198609113151103.

7. Litsey SE, Noonan JA, O’Connor WN, et al. Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med. 1985 Jan 10;312(2):98-100. doi: 10.1056/NEJM198501103120206.

8. McCune AB, Weston WL, Lee LA. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med. 1987 Apr;106(4):518-23. doi: 10.7326/0003-4819-106-4-518.

9. Silverman E, Mamula M, Hardin JA, Laxer R. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus. J Rheumatol. 1991 Jan;18(1):120-4.

10. Esscher E, Scott JS. Congenital heart block and maternal systemic lupus erythematosus. Br Med J. 1979 May 12;1(6173):1235-8. doi: 10.1136/bmj.1.6173.1235.

11. Bilazarian SD, Taylor AJ, Brezinskiy, et al. High-grade atrioventricular heart block in an adult with systemic lupus erythematosus: the association of nuclear RNP (U1 RNP) antibodies, a case report, and review of the literature. Arthritis Rheum. 1989 Sep;32(9):1170-4. doi: 10.1002/anr.1780320918.

12. Logar D, Kveder T, Rozman B, Dobovisek J. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis. 1990 Aug;49(8):627-9. doi: 10.1136/ard.49.8.627.

13. Maddison PJ. The neonatal lupus syndrome. Clin Exp Rheumatol. 1988 Apr-Jun;6(2):169-72.

14. Provost TT, Watson R, Gaither KK, Harley JB. The neonatal lupus erythematosus syndrome. J Rheumatol. Suppl. 1987 Jun;14 Suppl 13:199-205.

15. Boulware DW, Hedgpeth MT. Lupus pneumonitis and anti-SSA(Ro) antibodies. J Rheumatol. 1989 Apr;16(4):479-81.

16. Harley JB, Kaine JL, Fox OF, et al. Ro (SS-A) antibody and antigen in a patient with congenital complete heart block. Arthritis Rheum. 1985 Dec;28(12):1321-5. doi: 10.1002/art.1780281202.

17. Jaeggi E, Laskin C, Hamilton R, et al. The importance of the level of maternal antiRo/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol. 2010 Jun 15;55(24):2778-84. doi: 10.1016/j.jacc.2010.02.042.

18. Jones JV, Jones E, Forsyth SJ, et al. Familial systemic lupus erythematosus: evidence for separate loci controlling C4 deficiency and formation of antibodies to DNA, nRNP, Ro and La. J Rheumatol. 1987 Apr;14(2):263-7.

19. Alexander E, Buyon JP, Provost TT, Guarnieri T. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum. 1992Feb;35(2):176-89. doi: 10.1002/art.1780350209.

20. Buyon J, Szer I. Passively acquired autoimmunity and the maternal fetal dyad in systemic lupus erythematosus. Springer Semin Immunopathol. 1986;9(2-3):283-304. doi: 10.1007/BF02099027.

21. Lee LA, Coulter S, Erner S, Chu H. Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies. Am J Med. 1987 Oct;83(4):793-6. doi: 10.1016/0002-9343(87)90918-1.

22. Lee LA. The clinical spectrum of neonatal lupus. Arch Dermatol Res. 2009;301:107-10. doi: 10.1007/s00403-008-0896-4.

23. Lehman TJ, Reichlin M, Santner TJ, et al. Maternal antibodies to Ro (SS-A) are associated with both early onset of disease and male sex among children with systemic lupus erythematosus. Arthritis Rheum. 1989 Nov;32(11):1414-20. doi: 10.1002/anr.1780321110.

24. Lee LA, Weston WL. Cutaneous lupus erythematosus during the neonatal and childhood periods. Lupus. 1997;6(2):132-8. doi: 10.1177/096120339700600208.

25. Weston WL, Morreli JG, Lee L.A. The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus. Am J Acad Dermatol. 1999;40:675-81. doi: 10.1016/S0190-9622(99)70146-5.

26. Lee LA, Gaither KK, Coulter SN, et al. Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest. 1989;83:1556-62. doi: 10.1172/JCI1 14052.

27. Thornton CM, Eichenfield LF, Shinall EA, et al. Cutaneous telangiectases in neonatal lupus erythematosus. Am J Acad Dermatol. 1995;33:19-25. doi: 10.1016/0190-9622(95)90004-7.

28. Fox R, Hawkins DF. Fetal-pericardial effusion in association with congenital heart block and maternal systemic lupus erythematosus. Case report. Br J Obstet Gynaecol. 1990 Jul;97(7):638-40. doi: 10.1111/j.1471-0528.1990.tb02555.x.

29. Fox R, Lumb MR, Hawkins DF. Persistent fetal sinus bradycardia associated with maternal anti-Ro antibodies. Case report. Br J Obstet Gynaecol. 1990 Dec;97(12):1151-3. doi: 10.1111/j.1471-0528.1990.tb02506.x.

30. Franco HL, Weston WL, Peebles C, et al. Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome. J Am Acad Dermatol. 1981 Jan;4(1):67-72. doi: 10.1016/S0190-9622(81)70011-2.

31. McCue CM, Mantakas ME, Tingelstad JB, Ruddy S. Congenital heart block in newborns of mothers with connective tissue disease. Circulation. 1977 Jul;56(1):82-90. doi: 10.1161/01.CIR.56.1.82.

32. Stephensen O, Cleland WP, HallidieSmith K. Congenital complete heart block and persistent ductus arteriosus associated with maternal systemic lupus erythematosus. Br Heart J. 1981 Jul;46(1):104-6. doi: 10.1136/hrt.46.1.104.

33. Geggel RL, Tucker L, Szer I. Postnatal progression from second- to third-degree heart block in neonatal lupus syndrome. J Pediatr. 1988 Dec;113(6):1049-52. doi: 10.1016/S0022-3476(88)80581-X.

34. Hornberger LK, Al Rajaa N. Spectrum of cardiac involvement in neonatal lupus. Scand J Immunol. 2010 Sep;72(3):189-97. doi: 10.1111/j.1365-3083.2010.02437.x.

35. Llanos C, Izmirly PM, Katholi M, et al. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum. 2009 Oct;60(10):3091-7. doi: 10.1002/art.24768.

36. Friedman DM, Llanos C, Izmirly PM, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010 Apr;62(4):1138-46. doi: 10.1002/art.27308.

37. Pisoni CN, Brucato A, Ruffatti A, et al. Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. Arthritis Rheum. 2010 Apr;62(4):1147-52. doi: 10.1002/art.27350.

38. Petri M, Watson R, Hochberg MC. Anti-Ro antibodies and neonatal lupus. Rheum Dis Clin North Am. 1989 May;15(2): 335-60.

39. Buyon JP, Swersky SH, Fox HE, et al. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus. Experience in a mother with a predominance of SS-B (La) antibodies. Arthritis Rheum. 1987 Jan;30(1):44-9. doi: 10.1002/art.1780300106.

40. Derksen RH. Systemic lupus erythematosus and pregnancy. Rheumatol Int. 1991;11(3):121-5. doi: 10.1007/BF00304500.

41. Reid JM, Coleman EN, Doig W. Complete congenital heart block. Report of 35 cases. Br Heart J. 1982 Sep;48(3):236-9. doi: 10.1136/hrt.48.3.236.

42. Lee LA, Sokol RJ, Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics. 2002;109:E11. doi: 10.1542/peds.109.1.e11.

43. Prendiville JS, Cabral DA, Poskitt KJ, et al. Central nervous system involvement in neonatal lupus erythematosus. Pediatr Dermatol. 2003;20:60-7. doi: 10/1046/j.1525-1470.2003.03014.x.

44. Boros CA, Spence D, Blaser S, Silverman ED. Hydrocephalus and macrocephaly: new manifestations of neonatal lupus erythematosus. Arthritis Rheum. 2007;57:261-6. doi: 10.1002/art.22543.

45. Elcioglu N, Hall MC. Maternal systemic lupus erythematosus and chondrodysplasia punctata in two sibs: phenocopy or coincidence? J Med Genet. 1998;35:690-4. doi: 10.1136/jmg.35.8.690.

46. Chitayat D, Keating S, Zand DJ, et al. Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases. Am J Med Genet A. 2008 Dec 1;146A(23):3038-53. doi: 10.1002/ajmg.a.32554.

47. Shansker AL, Bernstein L, Herzog R. Chondrodysplasia punctata and maternal autoimmune disease: a new case and review of the literature. Pediatrics. 2007;120:e436-41. doi: 10.1542/peds.2006-2997.

48. Katayama I, Kondo S, Kawana S, et al. Neonatal lupus erythematosus with a high anticardiolipin antibody titer. Unusual variant of neonatal lupus erythematosus or earlyonset systemic lupus erythematosus? J Am Acad Dermatol. 1989 Sep;21(3 Pt 1):490-2. doi: 10.1016/S0190-9622(89)70213-9.

49. Silverman E, Jaeggi E. Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol. 2010;72:223-5. doi: 10.1111/j.1365-3083.2010.02443.x.

50. Buyon J, Roubey R, Swersky S, et al. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol. 1988 Jul;15(7):1104-8.

51. Barclay CS, French MA, Ross LD, Sokol RJ. Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies. Case report. Br J Obstet Gynaecol. 1987 Apr;94(4):369-71. doi: 10.1111/j.1471-0528.1987.tb03107.x.

52. Kaaja R, Julkunen H, Ammä lä P, et al. Congenital heart block: successful prophylactic treatment with intravenous gamma globulin and corticosteroid therapy. Am J Obstet Gynecol. 1991 Nov;165(5 Pt 1):1333-4. doi: 10.1016/S0002-9378(12)90755-3.

53. Tran HB, Ohlsson M, Beroukas D, et al. Subcellular redistribution of la/SSB autoantigen during physiologic apoptosis in the fetal mouse heart and conduction system: a clue to the pathogenesis of congenital heart block. Arthritis Rheum. 2002 Jan;46(1):202-8. doi: 10.1002/1529-0131(200201)46:1<202::AID-ART10062>3.0.CO;2-Y.

54. Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012 Jul 3;126(1):76-82. doi: 10.1161/CIRCULATIONAHA.111.089268. Epub 2012 May 24.

55. Carpenter RJ Jr, Strasburger JF, Garson A Jr, et al. Fetal ventricular pacing for hydrops secondary to complete atrioventricular block. J Am Coll Cardiol. 1986 Dec;8(6):1434-6. doi: 10.1016/S0735-1097(86)80319-9.

56. Martin TC, Arias F, Olander DS, et al. Successful management of congenital atrioventricular block associated with hydrops fetalis. J Pediatr. 1988 Jun;112(6):984-6. doi: 10.1016/S0022-3476(88)80231-2.


Для цитирования:


Кошелева Н.М., Алекберова З.С. Неонатальная волчанка. Современная ревматология. 2015;9(4):92-97. https://doi.org/10.14412/1996-7012-2015-4-92-97

For citation:


Kosheleva N.M., Alekberova Z.S. Neonatal lupus. Modern Rheumatology Journal. 2015;9(4):92-97. (In Russ.) https://doi.org/10.14412/1996-7012-2015-4-92-97

Просмотров: 468


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)